HA
KYTH

Havens Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Havens Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-33,300
Closed -$2.5M – 52
2015
Q3 		$2.5M Buy
33,300
+3,300
+11% +$246K 1.52% 19
2015
Q2 		$2.26M Buy
+30,000
New +$1.61M 1.68% 17

Havens Advisors's KYTH Position: Q4 2015 in Review

Havens Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 33,300 shares — an estimated $2.5M sold.

Havens Advisors first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $2.5M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Havens Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Havens Advisors sold 33,300 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $2.5M.
  • Havens Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
  • Havens Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.5M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Havens Advisors's 13F filing for Q4 2015, filed 28 Jan 2016.